Podcast

Share

Program Content

Activities

  • CDK4,6 Inhibition in Breast Cancer
    Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 09, 2024

    Expires: July 08, 2025

Provided by

ProCE Banner

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation